Vimarsana
Biggest News Aggregation in the World

Page 9 - Xlife Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xlife Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xlife Sciences Today - Breaking & Trending Today

FUSE-AI supports German pharmacies in digitization - Vimarsana News

FUSE-AI supports German pharmacies in digitization

04.07.2022 - Xlife Sciences AG / Key word(s): Miscellaneous FUSE-AI supports German pharmacies in digitization 04.07.2022 / 07:01 Xlife Sciences’ (SIX: XLS) project company FUSE-AI has been appointed as strategic partner in the field of digitization by the ... Seite 1

In brief: the IPO market and regulatory framework in Switzerland - Vimarsana News

In brief: the IPO market and regulatory framework in Switzerland

A look at some of the key market and regulatory issues surrounding initial public offerings in Switzerland, including market dynamics and prospectus requirements, among other things.

Project company Xsight Optics successfully participates in start-up competition – prize money finances relevant R&D project - Vimarsana News

Project company Xsight Optics successfully participates in start-up competition – prize money finances relevant R&D project

16.05.2022 Project company Xsight Optics successfully participates in start-up competition – prize money finances relevant R&D project | Xlife Sciences AG | News | Nachricht | Mitteilung

Source: dgap.de
Project company Xsight Optics successfully participates in start-up competition prize money finances relevant R&D project - Vimarsana News

Project company Xsight Optics successfully participates in start-up competition prize money finances relevant R&D project

Xlife Sciences AG / Key word(s): Miscellaneous Project company Xsight Optics successfully participates in start-up competition prize...

Xlife Sciences: First Valuation Report confirms substancial potential of the project portfolio and assumes CHF 574 million in the most conservative scenario Seite 1 - Vimarsana News

Xlife Sciences: First Valuation Report confirms substancial potential of the project portfolio and assumes CHF 574 million in the most conservative scenario Seite 1

09.05.2022 - Xlife Sciences AG / Key word(s): Miscellaneous Xlife Sciences: First Valuation Report confirms substancial potential of the project portfolio and assumes CHF 574 million in the most conservative scenario 09-May-2022 / 07:00 CET/CEST Release of an ... Seite 1